Skip to main content

Want a detailed portfolio tracker?

Performance analysis of Evaxion Biotech A/S (EVAX)

Annual Return

Over the past 3 years, EVAX has had an average annual return of -63.03%, underperforming the benchmark SPY, which returned +22.77% annual.

Over the past 5 years, EVAX has had an average annual return of -59.52%, underperforming the benchmark SPY, which returned +14% annual.

Since Feb 5, 2021, EVAX has had an average annual return of -60.01%, underperforming the benchmark SPY, which returned +15.01% annual.

202620252024202320222021
-20.83%+12.94%-87.73%-61.39%-59.83%-55.31%

Monthly Return

YearJanFebMarAprMayJunJulAugSepOctNovDecAnnually Total
2026-33.33%+0%+17.19%+18.67%-8.99%-6.17%-20.83%
2025-41.18%-22.00%-5.13%-16.22%+61.29%-0%+8%+3.70%+35.71%+52.63%+3.45%-20.00%+12.94%
2024-42.71%-8.31%-10.99%+30.25%-12.09%-21.02%-2.73%+8.07%+1.95%-14.01%-37.78%-49.40%-87.73%
2023-9.30%-4.36%-26.59%+11.46%+20.64%-13.79%-5.36%-33.09%+0.36%+34.44%-28.62%-14.23%-61.39%
2022-28.96%-3.18%-0.33%-7.60%-29.99%-2.07%+59.40%-23.21%+11.91%-1.13%-16.17%-18.56%-59.83%
2021-29.42%-15.47%+20.83%-5.47%+14.83%-30.23%+20.93%+47.61%-21.05%-38.77%-5.16%-55.31%

Drawdown analysis of Evaxion Biotech A/S (EVAX)

The maximum drawdown for the EVAX was -99.80%, occurring on Apr 16, 2025. This drawdown has not yet recovered.

The current EVAX drawdown is -99.41%.

Since Feb 5, 2021 EVAX has experienced the following drawdowns:

  • 50% or more: 1 time
  • 40% or more: 2 times
  • 30% or more: 2 times
  • 20% or more: 2 times
  • 10% or more: 2 times
DepthStartTo BottomBottomTo RecoverEndTotal
-99.80%Nov 4, 2021864Apr 16, 2025OngoingOngoingOngoing
-47.74%Feb 8, 202138Apr 5, 2021150Nov 4, 2021188